journal article·2022-07Open access

A Space‐Time Conversion Vehicle for Programmed Multi‐Drugs Delivery into Pancreatic Tumor to Overcome Matrix and Reflux Barriers

Taotao Huo, Xiaoyi Zhang, Min Qian, Huifang Nie, Dong Liang, Chenteng Lin, Yafeng Yang, Wei Guo, Ulrich Lächelt, Rongqin Huang

Advanced Science· Volume 9· Issue 20

Abstract

Abstract The numerous biological barriers, which limit pharmacotherapy of pancreatic carcinoma, including inadequate drug accumulation in the tumor environment, a dense extracellular matrix (ECM) and efficient drug‐efflux mechanisms, illustrate the requirement of multifunctional delivery systems to overcome the individual barriers at the right place at the right time. Herein, a space–time conversion vehicle based on covalent organic framework (COF)‐coated mesoporous silica nanospheres (MSN) with a sandwiched polyethyleneimine (PEI) layer (MPCP), is designed. The space‐specific drugs‐loaded vehicle (MGPPCLP) is obtained by separately incorporating a chemotherapeutic agent (gemcitabine, G) into the MSN core, a P glycoprotein inhibitor (LY 335979, P) into the PEI layer, and an extracellular matrix disruptor (losartan, L) into the COF shell. Thereafter, a programmed drug delivery is achieved via the ordered degradation from COF shell to MSN core. Sequential release of the individual drugs, synergized with a change of nanoparticle surface charge, contribute to an obvious extracellular matrix distraction, distinct drug efflux inhibition, and consequently enhance chemotherapeutic outcomes in pancreatic carcinoma. This MPCP‐based vehicle design suggests a robust space–time conversion strategy to achieve programmed multi‐drugs delivery and represents a new avenue to the treatment of pancreatic carcinoma by overcoming extracellular matrix and drug reflux barriers.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Covalent Organic Framework Applications · Metal-Organic Frameworks: Synthesis and Applications · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmaceutics School of Pharmacy Key Laboratory of Smart Drug Delivery Ministry of Education Fudan University Shanghai 201203 P. R. China

Department of Pharmaceutical Sciences University of Vienna Vienna 1090 Austria

Funding

National Natural Science Foundation of China · Program of Shanghai Academic Research Leader · Natural Science Foundation of Shanghai

References (25)

Show source-provided references
1. 10.1016/S0140-6736(20)30974-010.1016/S0140-6736(20)30974-0 ↗
2. 10.3390/ijms2018454310.3390/ijms20184543 ↗
3. 10.1038/s41571-019-0281-610.1038/s41571-019-0281-6 ↗
4. 10.1038/nrc.2016.6610.1038/nrc.2016.66 ↗
5. 10.1158/1078-0432.CCR-11-311410.1158/1078-0432.CCR-11-3114 ↗
6. 10.1097/PPO.000000000000028810.1097/PPO.0000000000000288 ↗
7. 10.1038/s41571-020-0363-510.1038/s41571-020-0363-5 ↗
8. 10.1016/j.ccr.2014.04.00510.1016/j.ccr.2014.04.005 ↗
9. 10.2174/1568009611313999007610.2174/15680096113139990076 ↗
10. 10.1007/s40262-020-00867-110.1007/s40262-020-00867-1 ↗
11. 10.3390/ijms2018450410.3390/ijms20184504 ↗
12. 10.1038/s41575-020-0300-110.1038/s41575-020-0300-1 ↗
13. 10.1038/ncomms351610.1038/ncomms3516 ↗
14. 10.1016/j.biopha.2021.11184410.1016/j.biopha.2021.111844 ↗
15. 10.7150/thno.3613510.7150/thno.36135 ↗
16. 10.1007/s11095-021-03072-210.1007/s11095-021-03072-2 ↗
17. 10.1021/nn404083m10.1021/nn404083m ↗
18. 10.1016/j.jconrel.2020.02.04010.1016/j.jconrel.2020.02.040 ↗
19. 10.1038/s41467-018-05906-x10.1038/s41467-018-05906-x ↗
20. 10.1039/C5CS00878F10.1039/C5CS00878F ↗
21. 10.1002/smll.20160032510.1002/smll.201600325 ↗
22. 10.1021/ja206846p10.1021/ja206846p ↗
23. 10.1021/acs.biomac.7b0029110.1021/acs.biomac.7b00291 ↗
24. 10.1186/s12943-018-0927-510.1186/s12943-018-0927-5 ↗
25. 10.3390/pharmaceutics802001210.3390/pharmaceutics8020012 ↗